Purchase of 100 acres farmland for $1.85 MillionThrough experienced partners, Red Light's Farm Division plan on growing mushroom production with...
Empower rebrands medical divison in the U.S. and accelerates access to the largest hospitals, medical centers and cruiseship opportunitesVANCOUVER, BC...
Pharnext shareholders approve 2021 financial statements and key resolutions at Annual General MeetingDr. James Kuo co-optation to the Board brings...
SAN DIEGO, CA / ACCESSWIRE / June 18, 2022 / WithHealth, Inc. (the "Company"), a digital precision care telehealth company...
Press Release Agreement with BARDA on ZENEO® Midazolam BARDA places a firm order of $60m to CROSSJECT for initial...
Mumbai, India, June 17, 2022 (GLOBE NEWSWIRE) -- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) (the “Company”), a platform technology...
Largest Acquisition to Date Will Provide Greater Access to Patient-Centered Care with Streamlined ServicesLOS ANGELES, CA / ACCESSWIRE / June...
Ottawa, Ontario--(Newsfile Corp. - June 17, 2022) - In a virtual roundtable with select professional association leaders convened by the...
Toronto, Ontario--(Newsfile Corp. - June 17, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a...
TORONTO, ON / ACCESSWIRE / June 17, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (the "Company") is pleased to announce...
mRNA-1273 was authorized for children and adolescents aged 6 months through 17 years of age, administered as two doses given...
JUPITER, FL / ACCESSWIRE / June 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced the purchase and retirement of...
ANAHEIM, CA, June 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
First demonstration of the survival of allogeneic islet cells, cardiomyocytes, and retinal pigment epithelium cells transplanted into an immunocompetent non-human...
Results to be Presented in Late-Breaking SessionSAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company...
MONTRÉAL, June 17, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions...
CY6463 alleviated mitochondrial dysfunction and reduced inflammation in preclinical models of mitochondrial complex 1 deficiency Data provide support for ongoing...
Collaboration with Merck published in Science magazine REDWOOD CITY, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS),...
Top-line Efficacy Results Expected in Approximately 6 to 8 WeeksBRIDGEWATER, N.J., June 17, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc....
Recent Company Submission in Response to FDA Request Extends PDUFA DateSOUTH SAN FRANCISCO, Calif., June 17, 2022 (GLOBE NEWSWIRE) --...